Compare LYEL & DAVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYEL | DAVEW |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | 274 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 681.3M | N/A |
| IPO Year | 2021 | N/A |
| Metric | LYEL | DAVEW |
|---|---|---|
| Price | $40.38 | $0.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 85.8K | 46.1K |
| Earning Date | 11-12-2025 | 03-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | $41,000.00 | ★ $319,355,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.00 |
| Revenue Growth | N/A | ★ 30.00 |
| 52 Week Low | $7.65 | $0.28 |
| 52 Week High | $45.00 | $0.32 |
| Indicator | LYEL | DAVEW |
|---|---|---|
| Relative Strength Index (RSI) | 82.04 | 57.51 |
| Support Level | $32.01 | $0.64 |
| Resistance Level | $45.00 | $0.72 |
| Average True Range (ATR) | 3.29 | 0.08 |
| MACD | 0.70 | 0.04 |
| Stochastic Oscillator | 79.16 | 94.81 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.